This is a sponsored article brought to you by MBZUAI. If you’ve ever tried to guess how a cell will change shape after a drug ...

When Microsoft researchers in 2023 identified a new kind of material that could dramatically reduce the amount of lithium ...

VANCOUVER, British Columbia, September 23, 2025--(BUSINESS WIRE)--Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the ...

Data readiness assessment is an important preparatory analysis that often complements discovery but it is narrower in scope. It evaluates data quality, availability, and governance, while the ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...

Vancouver firm's AI platform will generate chemical compounds based on Merck’s therapeutic targets. A Vancouver startup using artificial intelligence (AI) to discover new drugs has struck a deal with ...

Merck & Co. Inc., (NYSE:MRK) is one of the best conservative stocks to buy now. On September 23, the company confirmed a strategic collaboration with Variational AI to leverage its Enki Platform in ...

Macrocyclic compounds hold promise as therapeutic agents, yet their structural optimization is hindered by a scarcity of bioactive candidates. Here, the authors present CycleGPT, a generative chemical ...

格隆汇9月23日｜Variational AI宣布与默克公司达成合作，将生成式人工智能应用于药物研发。根据协议，该公司将获得一笔预付款，交易总潜在价值最高可达3.49亿美元。